Intralesional bleomycin sulfate injection for the treatment of verruca plantaris.
Sixty-two patients were treated for single or multiple warts by intralesional injection of bleomycin sulfate (1.5 U/mL) and then were observed for 6 months. The dose varied according to the size of the lesion and ranged from 0.25 to 1.0 mL per injection per lesion, up to a maximum dose of 3 mL. The total cure rate was 87% after one or two injections. Twelve of the 62 patients required a second injection.
Salk
Robert
R
Northern California Foot and Ankle Center, 45 Castro Street, San Francisco, CA 94114, USA.
Douglas
Troy S
TS
D000293:Adolescent; D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005533:Foot Dermatoses / Q000188:drug therapy*; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014860:Warts / Q000188:drug therapy*
D000964:Antimetabolites, Antineoplastic; D001761:Bleomycin